Escala pronóstica de Glasgow como predictor de mortalidad en pacientes oncológicos críticos

Objective

To determine if the Glasgow Prognostic Scale (EPG) is a predictor of mortality in critically ill cancer patients at the Instituto Especializado en Enfermedades Neoplásicas (IREN), Trujillo, Peru during 2022.

Material and methods

A cohort study was carried out. retrospective with 191 patients who were admitted to the Intensive Care Unit (ICU) of IREN, Trujillo, Peru during the previous 3 years. Clinical and laboratory variables, EPG and their association with mortality were evaluated through chi2, T-Student and multivariate analysis with binomial logistic regression.

Results

Of the 191 patients included in the study, 100 died (52.4%), with a mean age of 62.7 years and 51% were female. The variables that were associated with mortality in the multivariate analysis were BMI, days spent in the ICU, hemoglobin, and LDH.

Conclusions

The LDH component of the EPG is associated with mortality in critical cancer patients. In addition, they are variables associated with mortality, BMI, days of stay in the ICU, hemoglobin.